Skip to main content
Clinical Trials/KCT0007209
KCT0007209
Recruiting
未知

Combination therapy of Atherectomy plus drug-coated balloon versus drug-coated balloon for complex femoropopliteal artery disease

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Yonsei University Health System, Severance Hospital
Enrollment
300
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Age 19 years or older
  • 2\) Symptomatic peripheral artery disease:
  • \- Moderate or severe claudication (Rutherford category 2 or 3\)
  • \- Critical limb ischemia (Rutherford category 4 or 5\)
  • 3\) Femoropopliteal artery disease (stenosis \> 50%) with one of following complex lesion characteristics: \- long lesion (\>150 mm), in\-stent restenosis, calcified lesion (PACCS grade 2\-4\)
  • 4\) Femoropopliteal artery lesions that operators consider appropriate for treatment with both atherectomy plus drug\-coated balloons and drug\-coated balloons alone
  • 5\) Patients with signed informed consent

Exclusion Criteria

  • 1\) Acute critical limb ischemia
  • 2\) Severe critical limb ischemia (Rutherford category 6\)
  • 3\) Contraindication to any of the following medications: heparin, aspirin, clopidogrel, or contrast agents due to severe hypersensitive reactions
  • 4\) Age \> 85 years
  • 5\) Severe hepatic dysfunction (\> 3 times normal reference values)
  • 6\) Significant leucopenia, neutropenia, thrombocytopenia, anemia, or known bleeding diathesis
  • 7\) LVEF \< 35% or clinically overt congestive heart failure
  • 8\) Pregnant women or women with potential childbearing
  • 9\) Life expectancy \<1 year due to comorbidity
  • 10\) Previous bypass surgery or stenting in the target femoropopliteal artery

Outcomes

Primary Outcomes

Not specified

Similar Trials